The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infantile Spasm Treatment Market Research Report 2024
Synopsis
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasm Treatment market was valued at US$ 140 million in 2023 and is anticipated to reach US$ 184.8 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infantile Spasm Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infantile Spasm Treatment.
Report Scope
The Infantile Spasm Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infantile Spasm Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infantile Spasm Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
Segment by Type
Oral
Parenteral
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infantile Spasm Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global Infantile Spasm Treatment market was valued at US$ 140 million in 2023 and is anticipated to reach US$ 184.8 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Infantile Spasm Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infantile Spasm Treatment.
Report Scope
The Infantile Spasm Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infantile Spasm Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infantile Spasm Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
Segment by Type
Oral
Parenteral
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Infantile Spasm Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Infantile Spasm Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Parenteral
1.3 Market by Application
1.3.1 Global Infantile Spasm Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infantile Spasm Treatment Market Perspective (2019-2030)
2.2 Infantile Spasm Treatment Growth Trends by Region
2.2.1 Global Infantile Spasm Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Infantile Spasm Treatment Historic Market Size by Region (2019-2024)
2.2.3 Infantile Spasm Treatment Forecasted Market Size by Region (2025-2030)
2.3 Infantile Spasm Treatment Market Dynamics
2.3.1 Infantile Spasm Treatment Industry Trends
2.3.2 Infantile Spasm Treatment Market Drivers
2.3.3 Infantile Spasm Treatment Market Challenges
2.3.4 Infantile Spasm Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Infantile Spasm Treatment Players by Revenue
3.1.1 Global Top Infantile Spasm Treatment Players by Revenue (2019-2024)
3.1.2 Global Infantile Spasm Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Infantile Spasm Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Infantile Spasm Treatment Revenue
3.4 Global Infantile Spasm Treatment Market Concentration Ratio
3.4.1 Global Infantile Spasm Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Infantile Spasm Treatment Revenue in 2023
3.5 Infantile Spasm Treatment Key Players Head office and Area Served
3.6 Key Players Infantile Spasm Treatment Product Solution and Service
3.7 Date of Enter into Infantile Spasm Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Infantile Spasm Treatment Breakdown Data by Type
4.1 Global Infantile Spasm Treatment Historic Market Size by Type (2019-2024)
4.2 Global Infantile Spasm Treatment Forecasted Market Size by Type (2025-2030)
5 Infantile Spasm Treatment Breakdown Data by Application
5.1 Global Infantile Spasm Treatment Historic Market Size by Application (2019-2024)
5.2 Global Infantile Spasm Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Infantile Spasm Treatment Market Size (2019-2030)
6.2 North America Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Infantile Spasm Treatment Market Size by Country (2019-2024)
6.4 North America Infantile Spasm Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Infantile Spasm Treatment Market Size (2019-2030)
7.2 Europe Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Infantile Spasm Treatment Market Size by Country (2019-2024)
7.4 Europe Infantile Spasm Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Infantile Spasm Treatment Market Size (2019-2030)
8.2 Asia-Pacific Infantile Spasm Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Infantile Spasm Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Infantile Spasm Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Infantile Spasm Treatment Market Size (2019-2030)
9.2 Latin America Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Infantile Spasm Treatment Market Size by Country (2019-2024)
9.4 Latin America Infantile Spasm Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Infantile Spasm Treatment Market Size (2019-2030)
10.2 Middle East & Africa Infantile Spasm Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Infantile Spasm Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Infantile Spasm Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Mallinckrodt
11.1.1 Mallinckrodt Company Detail
11.1.2 Mallinckrodt Business Overview
11.1.3 Mallinckrodt Infantile Spasm Treatment Introduction
11.1.4 Mallinckrodt Revenue in Infantile Spasm Treatment Business (2019-2024)
11.1.5 Mallinckrodt Recent Development
11.2 H. Lundbeck
11.2.1 H. Lundbeck Company Detail
11.2.2 H. Lundbeck Business Overview
11.2.3 H. Lundbeck Infantile Spasm Treatment Introduction
11.2.4 H. Lundbeck Revenue in Infantile Spasm Treatment Business (2019-2024)
11.2.5 H. Lundbeck Recent Development
11.3 Insys Therapeutics
11.3.1 Insys Therapeutics Company Detail
11.3.2 Insys Therapeutics Business Overview
11.3.3 Insys Therapeutics Infantile Spasm Treatment Introduction
11.3.4 Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024)
11.3.5 Insys Therapeutics Recent Development
11.4 Orphelia Pharma
11.4.1 Orphelia Pharma Company Detail
11.4.2 Orphelia Pharma Business Overview
11.4.3 Orphelia Pharma Infantile Spasm Treatment Introduction
11.4.4 Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2019-2024)
11.4.5 Orphelia Pharma Recent Development
11.5 Valerion Therapeutics
11.5.1 Valerion Therapeutics Company Detail
11.5.2 Valerion Therapeutics Business Overview
11.5.3 Valerion Therapeutics Infantile Spasm Treatment Introduction
11.5.4 Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024)
11.5.5 Valerion Therapeutics Recent Development
11.6 Catalyst Pharmaceuticals
11.6.1 Catalyst Pharmaceuticals Company Detail
11.6.2 Catalyst Pharmaceuticals Business Overview
11.6.3 Catalyst Pharmaceuticals Infantile Spasm Treatment Introduction
11.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024)
11.6.5 Catalyst Pharmaceuticals Recent Development
11.7 Anavex Life Sciences
11.7.1 Anavex Life Sciences Company Detail
11.7.2 Anavex Life Sciences Business Overview
11.7.3 Anavex Life Sciences Infantile Spasm Treatment Introduction
11.7.4 Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2019-2024)
11.7.5 Anavex Life Sciences Recent Development
11.8 Retrophin
11.8.1 Retrophin Company Detail
11.8.2 Retrophin Business Overview
11.8.3 Retrophin Infantile Spasm Treatment Introduction
11.8.4 Retrophin Revenue in Infantile Spasm Treatment Business (2019-2024)
11.8.5 Retrophin Recent Development
11.9 GW Pharmaceuticals
11.9.1 GW Pharmaceuticals Company Detail
11.9.2 GW Pharmaceuticals Business Overview
11.9.3 GW Pharmaceuticals Infantile Spasm Treatment Introduction
11.9.4 GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024)
11.9.5 GW Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Infantile Spasm Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral
Table 4. Global Infantile Spasm Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Infantile Spasm Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Infantile Spasm Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Infantile Spasm Treatment Market Share by Region (2019-2024)
Table 8. Global Infantile Spasm Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Infantile Spasm Treatment Market Share by Region (2025-2030)
Table 10. Infantile Spasm Treatment Market Trends
Table 11. Infantile Spasm Treatment Market Drivers
Table 12. Infantile Spasm Treatment Market Challenges
Table 13. Infantile Spasm Treatment Market Restraints
Table 14. Global Infantile Spasm Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Infantile Spasm Treatment Market Share by Players (2019-2024)
Table 16. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasm Treatment as of 2023)
Table 17. Ranking of Global Top Infantile Spasm Treatment Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Infantile Spasm Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Infantile Spasm Treatment Product Solution and Service
Table 21. Date of Enter into Infantile Spasm Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Infantile Spasm Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Infantile Spasm Treatment Revenue Market Share by Type (2019-2024)
Table 25. Global Infantile Spasm Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Infantile Spasm Treatment Revenue Market Share by Type (2025-2030)
Table 27. Global Infantile Spasm Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Infantile Spasm Treatment Revenue Market Share by Application (2019-2024)
Table 29. Global Infantile Spasm Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Infantile Spasm Treatment Revenue Market Share by Application (2025-2030)
Table 31. North America Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Infantile Spasm Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Infantile Spasm Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Infantile Spasm Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Infantile Spasm Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Infantile Spasm Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Infantile Spasm Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Mallinckrodt Company Detail
Table 47. Mallinckrodt Business Overview
Table 48. Mallinckrodt Infantile Spasm Treatment Product
Table 49. Mallinckrodt Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 50. Mallinckrodt Recent Development
Table 51. H. Lundbeck Company Detail
Table 52. H. Lundbeck Business Overview
Table 53. H. Lundbeck Infantile Spasm Treatment Product
Table 54. H. Lundbeck Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 55. H. Lundbeck Recent Development
Table 56. Insys Therapeutics Company Detail
Table 57. Insys Therapeutics Business Overview
Table 58. Insys Therapeutics Infantile Spasm Treatment Product
Table 59. Insys Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 60. Insys Therapeutics Recent Development
Table 61. Orphelia Pharma Company Detail
Table 62. Orphelia Pharma Business Overview
Table 63. Orphelia Pharma Infantile Spasm Treatment Product
Table 64. Orphelia Pharma Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 65. Orphelia Pharma Recent Development
Table 66. Valerion Therapeutics Company Detail
Table 67. Valerion Therapeutics Business Overview
Table 68. Valerion Therapeutics Infantile Spasm Treatment Product
Table 69. Valerion Therapeutics Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 70. Valerion Therapeutics Recent Development
Table 71. Catalyst Pharmaceuticals Company Detail
Table 72. Catalyst Pharmaceuticals Business Overview
Table 73. Catalyst Pharmaceuticals Infantile Spasm Treatment Product
Table 74. Catalyst Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 75. Catalyst Pharmaceuticals Recent Development
Table 76. Anavex Life Sciences Company Detail
Table 77. Anavex Life Sciences Business Overview
Table 78. Anavex Life Sciences Infantile Spasm Treatment Product
Table 79. Anavex Life Sciences Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 80. Anavex Life Sciences Recent Development
Table 81. Retrophin Company Detail
Table 82. Retrophin Business Overview
Table 83. Retrophin Infantile Spasm Treatment Product
Table 84. Retrophin Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 85. Retrophin Recent Development
Table 86. GW Pharmaceuticals Company Detail
Table 87. GW Pharmaceuticals Business Overview
Table 88. GW Pharmaceuticals Infantile Spasm Treatment Product
Table 89. GW Pharmaceuticals Revenue in Infantile Spasm Treatment Business (2019-2024) & (US$ Million)
Table 90. GW Pharmaceuticals Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Infantile Spasm Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Infantile Spasm Treatment Market Share by Type: 2023 VS 2030
Figure 3. Oral Features
Figure 4. Parenteral Features
Figure 5. Global Infantile Spasm Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Infantile Spasm Treatment Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Infantile Spasm Treatment Report Years Considered
Figure 11. Global Infantile Spasm Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Infantile Spasm Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Infantile Spasm Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global Infantile Spasm Treatment Market Share by Players in 2023
Figure 15. Global Top Infantile Spasm Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasm Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Infantile Spasm Treatment Revenue in 2023
Figure 17. North America Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Infantile Spasm Treatment Market Share by Country (2019-2030)
Figure 19. United States Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Infantile Spasm Treatment Market Share by Country (2019-2030)
Figure 23. Germany Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Infantile Spasm Treatment Market Share by Region (2019-2030)
Figure 31. China Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Infantile Spasm Treatment Market Share by Country (2019-2030)
Figure 39. Mexico Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Infantile Spasm Treatment Market Share by Country (2019-2030)
Figure 43. Turkey Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Infantile Spasm Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Mallinckrodt Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 46. H. Lundbeck Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 47. Insys Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 48. Orphelia Pharma Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 49. Valerion Therapeutics Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 50. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 51. Anavex Life Sciences Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 52. Retrophin Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 53. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasm Treatment Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
